Theodore Quinlan
Nessuna posizione attualmente
Profilo
Theodore Quinlan is Vice President, Controller and Principal Accounting Officer of TranSwitch Corp., which he joined in October 2006.
He was Vice President-Finance and Chief Financial Officer of Molecular Staging, Inc. from 2003 to 2005 and resigned on January 15, 2007.
Mr. Quinlan received a BS degree in Business Administration from State University of New York College at Oswego and an MBA from Syracuse University.
Precedenti posizioni note di Theodore Quinlan
| Società | Posizione | Fine |
|---|---|---|
| TRANSWITCH CORPORATION | Comptroller/Controller/Auditor | 15/01/2007 |
Molecular Staging, Inc.
 Molecular Staging, Inc. Medical SpecialtiesHealth Technology Molecular Staging, Inc. (MSI) developed products for the detection & measurement of proteins and nucleic acids. The company's amplification technologies included products & services that identify individual and multiplexed sets of biomarkers & a method of generating DNA from a few cells. MSI enabled transformational products and services across multiple health care markets. The company was founded in 1998 and was located in New Haven, CT. | Direttore Finanziario/CFO | 15/01/2007 |
Formazione di Theodore Quinlan
| State University of New York College at Oswego | Undergraduate Degree |
| Syracuse University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRANSWITCH CORPORATION | Electronic Technology |
| Aziende private | 1 |
|---|---|
Molecular Staging, Inc.
Molecular Staging, Inc. Medical SpecialtiesHealth Technology Molecular Staging, Inc. (MSI) developed products for the detection & measurement of proteins and nucleic acids. The company's amplification technologies included products & services that identify individual and multiplexed sets of biomarkers & a method of generating DNA from a few cells. MSI enabled transformational products and services across multiple health care markets. The company was founded in 1998 and was located in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Theodore Quinlan
